期刊文献+

经皮肾镜钬激光碎石术和超声波碎石术治疗鹿角形肾结石疗效比较 被引量:6

Curative effect of high-power holmium laser lithotripsy versus ultrasonic lithotripsy for disintegration of staghorn stones during percutaneous nephrolithotomy
暂未订购
导出
摘要 目的比较经皮肾镜大功率钬激光碎石术(HP-HLL)与超声碎石术(US-L)治疗鹿角形肾结石的临床疗效。方法将2014年6月至2016年6月在我院泌尿外科治疗的120例鹿角形肾结石患者作为研究对象,根据随机数表法分为HP-HLL组(60例)和US-L组(60例)。所有患者都进行标准的俯卧位经皮肾取石术(PCNL)治疗。HPHLL组患者采用100 W钬激光仪以40~60 W(2 J,20~30 Hz)的参数进行碎石消解清除。US-L组使用EMS超声碎石机消解清除结石。比较两组患者Ⅰ期结石清除率、3个月后的结石清除率、手术并发症、术中出血量、手术时间、住院时间、血红蛋白下降值、肾小球滤过率。结果 13例患者未能随访,最终入选107例,其中HP-HLL组55例,US-L组52例。HP-HLL组患者的手术时间为(118.25±36.11)min,明显长于US-L组的(81.20±21.53)min,术中出血量为(116.3±26.5)mL,明显多于US-L组的(91.62±28.3)mL,患者的血红蛋白下降值为(1.3±0.6)g/dL,明显小于USL组的(1.7±0.9)g/dL,组间比较差异均具有统计学意义(P<0.05);HP-HLL组和US-L组患者的住院时间[(6.8±1.9)vs(6.4±2.1)d]、肾小球滤过率(14.6%vs 9.6%)、Ⅰ期结石清除率(74.5%vs 69.2%)、3个月后的结石清除率(89.1%vs86.5%)以及术后并发症(20.0%vs 19.2%)比较,差异均无统计学意义(P>0.05)。结论与在PCNL期间用于体内碎石的US-L碎石术相比,HP-HLL拥有较低的血红蛋白下降值,显示较好的安全性和有效性。 Objective To compare curative effect of high-power holmium laser lithotripsy (HP-HLL) and ultrasonic lithotripsy (US-L) for disintegration of staghorn stones during percutaneous nephrolithotomy (PCNL). Methods From June 2014 to June 2016, a total of 120 patients with staghorn stones hospitalized in our hospital were selected and divided into HP-HLL group and US-L group according to the random number table method, with 60 cases in each group. A standard PCNL in the prone position was performed for all patients. In the HP-HLL group, a laser power of 40~60 W (2 J, 20~30 Hz) was used to pulverise the staghorn stone into very small fragments, which could pass through the Amplatz sheath with the irrigation fluid. US-L, with suction of the fragments, was used in the US-L group. The stone-free rate of Ⅰ session and after 3 months, complications, intraoperative blood loss, operative time, hospital stay, haemoglobin deficit, glomerular filtration rate (GFR) were compared. Results Excluding non-follow-up patients, the final analysis included 107 patients, 55 in the HP-HLL group and 52 in the US-L group. Operative time of US-L group was (81.20±21.53) min, which was significantly shorter than (118.25±36.11) min of HP-HLL group (P〈0.05). The intraoperative blood loss of HP-HLL group was (116.3±26.5) mL which was significantly more than (91.62±28.3) mL of US-L group (P〈0.05). The haemoglobin deficit of HP-HLL group was (1.3 ± 0.6) g/dL, which was significantly lower than (1.7±0.9) g/dL in the US-L group (P〈0.05). The differences length of hospital stay, (6.8±1.9) d for HP-HLL group vs (6.4 ± 2.1) d for US-L group, changes of GFR (14.6% for HP-HLL vs 9.6% for US-L), stone-free rate of Ⅰ session (74.5%for HP-HLL vs 69.2%for US-L) and after 3 months (89.1%for HP-HLL vs 86.5%for US-L) and complication rates (20.0%for HP-HLL vs 19.2%for US-L) were not significant (P〉0.05). Conclusion Compared with US-L for in-tracorporeal lithotripsy of staghorn stones during PCNL, HP-HLL showed better safety and efficacy with a lower haemo-globin deficit.
出处 《海南医学》 CAS 2017年第10期1587-1589,共3页 Hainan Medical Journal
关键词 经皮肾镜碎石 鹿角形结石 激光碎石术 超声波碎石术 疗效 Percutaneous nephrolithotomy (PCNL) Staghorn stones Laser lithotripsy Ultrasonic lithotripsy(US-L) Curative effect
  • 相关文献

参考文献7

二级参考文献63

  • 1张贵福,杨金普,王跃强,黄曦,杨智明.微创经皮肾镜钬激光碎石治疗肾结石150例报告[J].中国微创外科杂志,2008,8(4):316-317. 被引量:11
  • 2邵雪峰,蒋廷,刘锋,李晓君,孙伟.输尿管镜下钬激光与气压弹道碎石治疗不同分段输尿管结石142例疗效分析[J].黑龙江医学,2013,37(12):1176-1178. 被引量:4
  • 3陈勇,潘文博,赖广平,梁聪.经皮肾镜取石术治疗肾结石(附56例报告)[J].广西医学,2006,28(5):681-682. 被引量:22
  • 4那彦群,叶章群,等.2011版中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2011.
  • 5Pugh JW, Canales BK. New instrumentation in percutaneous nephrolithotomy. Indian J Urol, 2010, 26(3): 389-394.
  • 6Hofmann R, Olbert P, Weber J, et al. Clinical experience with a new ultrasonic and Litboclast combination f or percutaneous litholapaxy. BJU Int, 2002, 90(1): 16-19.
  • 7Goldman DM, Pedro RN, Kossctt A, et al. Maximizing stone fragmentation efficiency with ultrasonic probes: impact of probe pressure and rotation. J Urol, 2009, 181(3): 1429-1433.
  • 8Xu Y, Wu Z, Yu J, et al. Doppler ultrasound-guided percutaneous nephrolithotomy with two-step tract dilation for management of complex renal stones. Urology, 2012, 79(6): 1247-1251.
  • 9Kim SC, Matlaga BR, Tinmouth WW, et al. In vitro assessment of a novel dual probe ultrasonic in tracorporeal lithotriptor. J Urol, 2007, 177(4): 1363-1365.
  • 10Krambeck AE, Miller NL, Humphreys MR, et al. Randomized controlled, multicentre clinical trial comparing a dual probe ultrasonic litbotrite with a single probe lithotrlte for percutaneous nephrolithotomy. BJU Int, 2011, 107(5): 824-828.

共引文献57

同被引文献43

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部